Figure 2. Observed and Predicted Risk in Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial (PARADIGM-HF) at 2 Years for Primary Composite End Point (A), Cardiovascular Death (B), and All-Cause Mortality for Patients Categorized by Quintile of Risk Score (C).

A, Predicted vs observed risk of primary composite end point at 2 years. B, Predicted vs observed risk of cardiovascular death at 2 years. C. Predicted vs observed risk of all-cause mortality at 2 years.